Cardiovascular protection for all individuals at high risk: evidence-based best practice.
Patients with cardiovascular risk factors are largely undertreated, for many reasons. Vulnerable individuals may not be aware of the risks they are facing or an individual's risk of cardiovascular disease may be underestimated, particularly among those at high risk. Furthermore, in individuals identified as being at high total cardiovascular risk, the full spectrum of therapeutic options may not be implemented or patients may not adhere to the treatment prescribed. We address these critical issues by summarizing the existing guidelines: our ultimate goal is to encourage the optimal management of individuals at high total cardiovascular risk according to evidence-based medicine, with the expectation that this will improve outcomes.
Bakris
George
G
Department of Medicine, Hypertensive Diseases Unit, University of Chicago-Pritzker School of Medicine, Chicago, IL, USA.
Böhm
Michael
M
Dagenais
Gilles
G
Diener
Hans-Christoph
HC
Fujita
Toshiro
T
Gorelick
Philip
P
Kjeldsen
Sverre Erik
SE
Laakso
Markku
M
Mancia
Giuseppe
G
Pitt
Bertram
B
Sharma
Arya
A
Sleight
Peter
P
Teo
Koon
K
Unger
Thomas
T
Weber
Michael
M
Williams
Bryan
B
Zannad
Faiez
F
D019985:Benchmarking; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
D002316:Cardiotonic Agents